Heron Therapeutics | 販売および管理費





販売および管理費 変化する 日付
ALKERMES USD 171.77M 17.9M 2025-09
Alnylam Pharmaceuticals USD 262.59M 60.72M 2025-09
Amarin USD 17.94M 17.86M 2025-09
ANI Pharmaceuticals USD 76.66M 5.11M 2025-09
Anika Therapeutics USD 12.91M 17.8M 2025-03
Arrowhead Research USD 46.02M 8.84M 2025-12
Eisai JPY 111.72B 7.86B 2025-12
Esperion Therapeutics USD 39.98M 4.21M 2024-09
GlaxoSmithKline GBP 2.68B 518M 2025-12
Heron Therapeutics USD 23.34M 4.18M 2024-09
Insmed USD 186.38M 109.94M 2025-09
Ligand Pharmaceuticals USD 28.45M 8.27M 2025-09
Merck USD 2.85B 215M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Neurocrine Biosciences USD 291.6M 5.3M 2025-09
Omeros USD 11.32M 2.48M 2024-09
Pacira USD 91.8M 14.6M 2025-09
Regeneron Pharmaceuticals USD 775M 117.2M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Surmodics USD 14.58M 2.05M 2024-09
Ultragenyx Pharmaceutical USD 86.62M 26K 2025-09
Veracyte USD 51.73M 5.91M 2025-09
Vertex Pharmaceuticals USD 445.1M 20.5M 2025-09


Heron Therapeutics 販売および管理費 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Feb 2026.